Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future</p>
Leslie Citrome, Joseph P. McEvoy, Mark S. Todtenkopf, et al.
Neuropsychiatric Disease and Treatment (2019) Vol. Volume 15, pp. 2559-2569
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

MGNDTI: A Drug-Target Interaction Prediction Framework Based on Multimodal Representation Learning and the Gating Mechanism
Lihong Peng, Xin Liu, Min Chen, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 16, pp. 6684-6698
Closed Access | Times Cited: 6
New Antipsychotic Medications in the Last Decade
Mehak Pahwa, Ahmad Sleem, Omar H. Elsayed, et al.
Current Psychiatry Reports (2021) Vol. 23, Iss. 12
Closed Access | Times Cited: 35
The cognitive (lateral) hypothalamus
Melissa J. Sharpe
Trends in Cognitive Sciences (2023) Vol. 28, Iss. 1, pp. 18-29
Open Access | Times Cited: 13
Efficacy and safety evaluation of olanzapine treatment for schizophrenia patients: A retrospective data analysis
Jingyuan Li, Fangyu Chen
Archives of Psychiatric Nursing (2025) Vol. 54, pp. 26-30
Closed Access
Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
Mulualem Kelebie, Getasew Kibralew, Gebresilassie Tadesse, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A Case of Olanzapine Resistance from Heavy Smoking and Clinical Considerations
Kamalakar Surineni, Andrew B. Smith, Rachel Glein, et al.
Kansas Journal of Medicine (2025) Vol. 18, Iss. 1, pp. 21-22
Closed Access
Effect of olanzapine on testes of adult albino rats and the possible role of granulocyte colony stimulating factor versus umbelliferone light and electron microscopic study
Maha A. Khattab, Samah Ahmed, Hosni Salama, et al.
Ultrastructural Pathology (2025), pp. 1-23
Closed Access
Association of family history of schizophrenia and clinical outcomes in individuals with eating disorders
Ruyue Zhang, Ralf Kuja‐Halkola, Andreas Birgegård, et al.
Psychological Medicine (2021), pp. 1-8
Open Access | Times Cited: 25
Second-generation antipsychotics and metabolic syndrome: a role for mitochondria
Katherine R. H. Mortimer, Mohammed Zia Ul Haq Katshu, Lisa Chakrabarti
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Prevalence and Cost of Antipsychotic Prescribing, within the Context of Psycholeptic Prescribing, in the Irish Setting
M. Vaughan, Siobhán Lucey, Laura J. Sahm
Healthcare (2024) Vol. 12, Iss. 3, pp. 338-338
Open Access | Times Cited: 3
A new olanzapine cocrystal obtained from volatile deep eutectic solvents and determined by 3D electron diffraction
Iryna Andrusenko, Jason Potticary, Simon R. Hall, et al.
Acta Crystallographica Section B Structural Science Crystal Engineering and Materials (2020) Vol. 76, Iss. 6, pp. 1036-1044
Open Access | Times Cited: 27
Olanzapine-induced nonalcoholic fatty liver disease: The effects of differential food pattern and the involvement of PGRMC1 signaling
Zhenyu Zhu, Ting Cao, Hui Chen, et al.
Food and Chemical Toxicology (2023) Vol. 176, pp. 113757-113757
Closed Access | Times Cited: 8
Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study
Dolores Keating, Stephen McWilliams, Fiona Boland, et al.
BMJ Open (2021) Vol. 11, Iss. 1, pp. e040387-e040387
Open Access | Times Cited: 20
Specific Anti-hostility Effects of Atypical Antipsychotics in Persons with Schizophrenia: From Clozapine to Cariprazine
Leslie Citrome, Jan Volavka
Harvard Review of Psychiatry (2021) Vol. 29, Iss. 1, pp. 20-34
Closed Access | Times Cited: 19
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder
Leslie Citrome, Christine Graham, Adam Simmons, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2885-2904
Open Access | Times Cited: 16
Development and evaluation of a drug-in-adhesive transdermal delivery system for delivery of olanzapine
Deepal Vora, Ajay K. Banga
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 11, pp. 1539-1548
Closed Access | Times Cited: 11
Discovery and optimization of olanzapine derivatives as new ferroptosis inhibitors
Xiufen Jiang, Xifeng Teng, Huiwen Shi, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106393-106393
Closed Access | Times Cited: 6
Opioid antagonism mitigates antipsychotic-associated weight gain: focus on olanzapine
Roger S. McIntyre, Leslie Citrome, Hannah Cummings, et al.
CNS Spectrums (2022) Vol. 28, Iss. 3, pp. 288-299
Open Access | Times Cited: 9
Delayed-Onset olanzapine-induced rhabdomyolysis
Jun Hua Lim, Billy Robinson, Judy Savige
BMJ Case Reports (2023) Vol. 16, Iss. 3, pp. e254377-e254377
Closed Access | Times Cited: 5
Olanzapine Pharmacokinetics: A Clinical Review of Current Insights and Remaining Questions
Priyanka Kolli, Grace Kelley, Marianela Rosales, et al.
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 1097-1108
Open Access | Times Cited: 5
The treatment of acute agitation associated with schizophrenia or bipolar disorder: investigational drugs in early stages of their clinical development, and their clinical context and potential place in therapy
Kristen M. Ward, Leslie Citrome
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 3, pp. 245-257
Closed Access | Times Cited: 13
The Effect of Neuropsychiatric Drugs on the Oxidation-Reduction Balance in Therapy
Karina Sommerfeld, Wiktoria Jiers, Szymon Rzepczyk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7304-7304
Open Access | Times Cited: 1
Aripiprazole, but Not Olanzapine, Alters the Response to Oxida-Tive Stress, Reducing the Activation of Mitogen-Activated Protein Kinases (MAPKs) and Promoting Cell Survival in FAO Cells
Barbara Kramar, Tinkara Pirc Marolt, Ayşe Mine Yılmaz, et al.
(2024)
Open Access | Times Cited: 1
Radical Scavenging and Anti-Ferroptotic Molecular Mechanism of Olanzapine: Insight from a Computational Analysis
Davide Zeppilli, Giacomo Grolla, Valerio Di Marco, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 46, pp. 21856-21867
Closed Access | Times Cited: 1
Aripiprazole, but Not Olanzapine, Alters the Response to Oxidative Stress in Fao Cells by Reducing the Activation of Mitogen-Activated Protein Kinases (MAPKs) and Promoting Cell Survival
Barbara Kramar, Tinkara Pirc Marolt, Ayşe Mine Yılmaz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11119-11119
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top